Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.
By MOHAMMED N. Khan, P. Jaïs, J. Cummings, L. Di Biase, P. Sanders, David O. Martin, J. Kautzner, S. Hao, S. Themistoclakis, R. Fanelli and 19 more. New England Journal of Medicine, 2008
707 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/cce5f6539ed0ae7e494c60cb6979c6b1114e53fc
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- Stanley Nattel
- Gerhard Hindricks
- Ulrich Schotten
- A. Goette
- Paulus Kirchhof
- M. Ezekowitz
- Gregory Y. H. Lip
- Jeroen J. Bax
Citations in the corpus
- 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design (2012, result): “Another study is the Pulmonary Vein Antrum Isolation versus AV Node Ablation with Bi-Ventricular Pacing for Treatment of AF in Patients with Congestive Heart Failure (PABA-CHF) study that compared the efficacy of AF ablation with AV node ablation and pacemaker implantation [520].”
- Dilated Cardiomyopathy (2007, positive): “Catheter ablation is a wellestablished option for symptomatic atrial fibrillation that is resistant to drug therapy in patients with otherwise normal cardiac function, and various studies have shown that ablation is associated with positive outcomes in patients with heart failure [47].”
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 (2012, background): “The role of catheter ablation as a rhythm control strategy in HF is at present uncertain.(174,175)”
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2016, neutral): “I A 223–226, 388 Several strategies should be considered to reduce recurrent symptomatic arrhythmias in patients with an ICD (or in those who are not eligible for ICD), including attention to risk factors and optimal pharmacological treatment of HF, amiodarone, catheter ablation and CRT. IIa C Routi”